Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases

Curr Neuropharmacol. 2020;18(11):1054-1063. doi: 10.2174/1570159X17666191113103850.

Abstract

Until recently, it was thought that there were no lymphatic vessels in the central nervous system (CNS). Therefore, all metabolic processes were assumed to take place only in the circulation of the cerebrospinal fluid (CSF) and through the blood-brain barrier's (BBB), which regulate ion transport and ensure the functioning of the CNS. However, recent findings yield a new perspective: There is an exchange of CSF with interstitial fluid (ISF), which is drained to the paravenous space and reaches lymphatic nodes at the end. This circulation is known as the glymphatic system. The glymphatic system is an extensive network of meningeal lymphatic vessels (MLV) in the basal area of the skull that provides another path for waste products from CNS to reach the bloodstream. MLV develop postnatally, initially appearing around the foramina in the basal part of the skull and the spinal cord, thereafter sprouting along the skull's blood vessels and spinal nerves in various areas of the meninges. VEGF-C protein (vascular endothelial growth factor), expressed mainly by vascular smooth cells, plays an important role in the development of the MLV. The regenerative potential and plasticity of MLV and the novel discoveries related to CNS drainage offer potential for the treatment of neurodegenerative diseases such as dementia, hydrocephalus, stroke, multiple sclerosis, and Alzheimer disease (AD). Herein, we present an overview of the structure and function of the glymphatic system and MLV, and their potential involvement in the pathology and progression of neurodegenerative diseases.

Keywords: Glymphatic system; aquaporin-4; blood-brain barrier (BBB); cerebrospinal fluid (CSF); clinical perspective; functional anatomy; interstitial fluid of the brain; meningeal lymphatic vessels (MLV); neurodegenerative disorders.

Publication types

  • Review

MeSH terms

  • Amyloid beta-Peptides / metabolism
  • Animals
  • Blood-Brain Barrier / metabolism
  • Brain / metabolism
  • Brain / pathology
  • Central Nervous System / metabolism*
  • Glymphatic System / metabolism
  • Humans
  • Neurodegenerative Diseases / metabolism
  • Spinal Cord / metabolism

Substances

  • Amyloid beta-Peptides